您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > Sintilimab
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Sintilimab
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
CAS NO:2072873-06-2
包装与价格:
包装价格(元)
1mg电议
5mg电议

产品介绍
Sintilimab (IBI308) 是一种人源化的 IgG4 单克隆抗体,可与 PD-1 结合,从而阻断 PD-1 与其配体 (PD-L1 和 PL-L2) 的相互作用,从而有助于恢复内源性抗肿瘤 T 细胞反应。Sintilimab 可用于经典霍奇金淋巴瘤、非小细胞肺癌和食管癌的研究。
Cas No.2072873-06-2
别名信迪利单抗,IBI308
储存条件Store at 4℃, do not freeze
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

Sintilimab (IBI308) is a fully human IgG4 monoclonal antibody that binds to PD-1, thereby blocking the interaction of PD-1 with its ligands (PD-L1 and PL-L2) and consequently helping to restore the endogenous antitumour T-cell response. Sintilimab can be used for the research of classical Hodgkin's lymphoma, non-small cell lung cancer and oesophageal cancer[1].

[1]. Sheridan M Hoy. Sintilimab: First Global Approval Drugs. 2019 Feb;79(3):341-346.